Weighted Average Number of Shares Outstanding, Diluted of BICYCLE THERAPEUTICS PLC from 2019 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Bicycle Therapeutics Plc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from 2019 to Q3 2025.
  • Bicycle Therapeutics Plc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 69.3M shares, a 0.46% increase year-over-year.
  • Bicycle Therapeutics Plc annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 58.2M shares, a 63.5% increase from 2023.
  • Bicycle Therapeutics Plc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 35.6M shares, a 20% increase from 2022.
  • Bicycle Therapeutics Plc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 29.7M shares, a 18.4% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

BICYCLE THERAPEUTICS PLC Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 69.3M +315K +0.46% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 69.3M +17.3M +33.2% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025
Q1 2025 69.2M +26.6M +62.6% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025
Q4 2024 58.2M +22.6M +63.5% 01 Oct 2024 31 Dec 2024 10-K 25 Feb 2025
Q3 2024 69M +29.4M +74.3% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025
Q2 2024 52M +21.8M +72.2% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025
Q1 2024 42.6M +12.6M +41.9% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025
Q4 2023 35.6M +5.93M +20% 01 Oct 2023 31 Dec 2023 10-K 25 Feb 2025
Q3 2023 39.6M +9.9M +33.4% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024
Q2 2023 30.2M +543K +1.83% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024
Q1 2023 30M +397K +1.34% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024
Q4 2022 29.7M +4.6M +18.4% 01 Oct 2022 31 Dec 2022 10-K 25 Feb 2025
Q3 2022 29.7M +4.64M +18.5% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023
Q2 2022 29.6M +5.6M +23.3% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023
Q1 2022 29.6M +7.5M +34% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023
Q4 2021 25.1M 01 Oct 2021 31 Dec 2021 10-K 20 Feb 2024
Q3 2021 25M +5.61M +28.9% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022
Q2 2021 24.1M +5.97M +33% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022
Q1 2021 22.1M 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022
Q3 2020 19.4M 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021
Q2 2020 18.1M 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021

BICYCLE THERAPEUTICS PLC Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 58.2M +22.6M +63.5% 01 Jan 2024 31 Dec 2024 10-K 25 Feb 2025
2023 35.6M +5.93M +20% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2025
2022 29.7M +4.6M +18.4% 01 Jan 2022 31 Dec 2022 10-K 25 Feb 2025
2021 25.1M +5.92M +30.9% 01 Jan 2021 31 Dec 2021 10-K 20 Feb 2024
2020 19.1M +8.1M +73.3% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023
2019 11M 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.